⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Influenza Vaccination (Heterologous Longevity Effects)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-12 — Influenza vaccination as a modulator of inflammaging: trained tolerance as a mechanistic lens on heterologous effects in age-related diseases.: Narrative review (2024) proposes trained tolerance — persistent myeloid epigenetic remodelling documented in murine causal experiments and single-cell multiomics — as the mechanistic bridge between influenza vaccination and reduced cardiovascular, neurodegenerative and cardio-renal disease burden observed in epidemiology; framed as inflammaging modulation, not a new outcome trial. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Influenza vaccination as a modulator of inflammaging: trained tolerance as a mechanistic lens on heterologous effects in age-related diseases.
12-sep-2026
novelty 3
per-area 3
strengthens